Amwell makes grant to new employees under inducement plan

Rhea-AI Summary

Amwell (NYSE: AMWL), a technology-enabled care platform provider, has granted 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements. The RSUs follow a four-year vesting schedule, with 25% vesting after one year and the remaining 75% vesting quarterly over three years.

The grants were approved by Amwell's Compensation Committee under the company's Inducement Plan, complying with NYSE's Listed Company Manual Rule 303A.08.

Positive

• Equity-based compensation aligns new employee interests with shareholders
• Structured vesting schedule helps retain talent for 4 years

Negative

• Potential dilution from 76,198 new shares

BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell^® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees’ employment with Amwell. The RSUs will vest as follows, subject to the applicable employee’s continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) for three years until such RSUs are vested in full.

The grants described in this press release were approved by the Compensation Committee of the Amwell’s Board of Directors pursuant to the Amwell’s Inducement Plan and made in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08. Amwell is issuing this press release pursuant to Rule 303A.08.

About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Media:
Press@amwell.com

Investor:
Sue Dooley
Sue.Dooley@amwell.com

Notice of Ownership
All materials contained herein are the property of American Well Corporation and are copyrighted under United States law and applicable international copyright laws and treaty provisions. The materials contained herein are not work product or "work for hire" on behalf of any third party. The materials contained herein constitute the confidential information of American Well Corporation, except for specific data elements provided by third parties, which are the confidential information of such third parties. The content contained herein results from the application of American Well proprietary processes, analytical frameworks, algorithms, business methods, solution construction aids and templates, all of which are and remain the property of American Well Corporation.

Trademark Notice
All of the trademarks, service marks and logos displayed on these materials (the "Trademark(s)") are registered and unregistered trademarks of American Well Corporation or third parties who have licensed their Trademarks to American Well Corporation. Except as expressly stated in these terms and conditions, you may not reproduce, display or otherwise use any Trademark without first obtaining American Well Corporation's written permission.

FAQ

What type of stock grants did Amwell (AMWL) issue to new employees?

Amwell issued 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements.

What is the vesting schedule for Amwell's new employee RSU grants?

The RSUs vest over 4 years, with 25% vesting after the first year and the remaining 75% vesting in quarterly increments over the following three years.

How many new employees received RSU grants from Amwell?

Two new employees received RSU grants from Amwell.

Under what authority did Amwell issue these inducement grants?

The grants were approved by Amwell's Compensation Committee under the company's Inducement Plan, in compliance with NYSE's Listed Company Manual Rule 303A.08.